138 Per Cent Returns From 52-Week Low: Board Announces 2:1 Stock Split & Migration From SME to Main Board on BSE & NSE
The stock gave multibagger returns of 138 per cent from its 52-week low of Rs 988 per share.
The Company informed that the Board of Directors of Jeena Sikho Lifecare Limited has, at its meeting held today, April 21, 2025, considered and approved the sub-division/split of the company's existing equity shares from one share with a face value of ₹10 each into five equity shares with a face value of ₹2 each, fully paid-up, with the record date for this sub-division/split to be announced in due course; additionally, the Board has also approved the migration of the company's listed equity shares from the NSE Emerge platform to the Main Board of the National Stock Exchange of India Limited (NSE) and the main board of BSE Ltd (BSE), subject to the necessary approvals from the company's members and relevant regulatory authorities.
Jeena Sikho Lifecare has become a significant Ayurvedic healthcare provider in India with a decade of service, offering diverse products and actively engaging in public health through free checkups and yoga sessions to promote wellness. Their extensive network includes 119 clinics and hospitals, including specialised HIIMS and Shuddhi Panchakarma centres, enabling personalised treatments and distribution of over 300 products; a testament to their quality is the NABH accreditation of 17 facilities.
DSIJ’s 'multibagger Pick’ service recommends well researched multibagger stocks with High Returns potential. If this interests you, do download the service details here.
The company plans to establish a new 150-bed hospital in Raigad District, Maharashtra, on leased property in Village Karnala, Taluka Panvel, with operations commencing in July 2025. This strategic expansion, requiring an estimated Rs 6 crore investment from internal funds, aims to broaden their healthcare network and extend quality medical services to a wider population in the region.
The shares of the company have an ROE of 43 per cent and an ROCE of 58 per cent. The stock gave multibagger returns of 138 per cent from its 52-week low of Rs 988 per share. Investors should keep an eye on this stock.
Disclaimer: The article is for informational purposes only and not investment advice.